Tag Archive for: Acadia

FDA action alert: Roche and Acadia

, , , ,

After the flurry of verdicts and meetings at the end of February, the FDA has a relatively quiet week ahead with only two stand-out events.

Read more
/by

U.S. FDA declines to approve expanded use of Acadia’s antipsychotic drug

“We are disappointed with this outcome. The treatment of Alzheimer’s disease psychosis continues to be an area of high unmet need, for which there is no approved therapy,” said company CEO Steve Davis.

Read more
/by